RxDoctor Payments Data

Regina Carson, APRN

Family · Robbins, TNNPI 1376044453

Payments from drug & device makers

$470in general payments, 2019–2025

Across 27 payments — averaging $17.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$107
  • GSK$85
  • Novo Nordisk$82
  • Otsuka America Pharmaceutical, Inc.$49
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$38
  • Teva Pharmaceuticals USA, Inc.$34
  • plus $76 from 4 others

What the payments were for

  • Food & beverage$470100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$470 in reported general payments places this provider in the 50th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$3,886
Medicare patients
64
Services billed
269

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide144$135,975
MounjaroTirzepatide99$111,114
EliquisApixaban126$85,594
LinzessLinaclotide80$52,619
Trelegy ElliptaFluticasone/Umeclidin/Vilanter71$50,295
FarxigaDapagliflozin Propanediol56$47,473
JardianceEmpagliflozin54$41,130
VraylarCariprazine Hcl21$33,755
RybelsusSemaglutide16$30,376
JanuviaSitagliptin Phosphate25$19,164
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr36$18,216
Breztri AerosphereBudesonide/Glycopyr/Formoterol25$16,083
TrulicityDulaglutide15$14,541
UbrelvyUbrogepant11$11,430
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen188$7,402

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$82$166,352160 claims
AbbVieLinzess, Vraylar, Ubrelvy$107$97,804112 claims
GSKTrelegy Ellipta, Anoro Ellipta$85$68,511107 claims
AstraZenecaFarxiga, Breztri Aerosphere$16$63,55681 claims
Boehringer IngelheimJardiance, Combivent Respimat, Spiriva Respimat$16$55,21780 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 6,706 family providers in Tennessee.

Other family in Robbins

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →